Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

341
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

201
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

SEROPREVALENCE OF HEPATITIS C VIRUS AMONG BLOOD DONORS IN MIDDLEEASTERN COUNTRIES: A SYSTEMATIC REVIEW AND META-ANALYSIS

Pages

  0-0

Abstract

 Context: HEPATITIS C virus (HCV) has been the main cause of post transfusion hepatitis. Long-term HEPATITIS Can ultimately result incirrhosis and hepatocellular carcinoma. Viral hepatitis, especially HCV infection, is a major health concern in the MIDDLE EAST. Thecurrent study carried out a systematic search concerning HCV seroprevalence among blood donors in MIDDLE EASTern countries. Evidence Acquisition: Articles were identified through searching databases including PubMed, Scopus, and Web of Science. Wereviewed systematically all studies reporting HCV seroprevalence among blood donors in MIDDLE EASTern countries. Results: A total of 5662 relevant records were identified by the electronic search, of which a total of 47 studies were identified aseligible papers that were meta-analyzed for the pooled seroprevalence of HCV among blood donors. Overall, HCV seroprevalenceamong blood donors in MIDDLE EASTern countries was estimated 0. 88% (95%CI = 0. 79%-0. 97%). The highest pooled HCV seroprevalencerate was related to Egypt (5. 76% [95%CI = 3. 30%-8. 22%]), Libya (1. 56% [95%CI = 0. 99%-2. 13%]), and Yemen (1. 09% [95%CI = 0. 69%-1. 50%]) while the lowest pooled seroprevalence rate was in Iran and Israel with the rates of 0. 14% (95%CI = 0. 12%-0. 17%) and 0. 16%(95%CI = 0. 06%-0. 25%), respectively. Results of annual HCV seroprevalence suggest that there is a decrease in seroprevalence rate ofHCV over time among blood donors in Egypt, Iran, Oman, Lebanon, Libya, and Saudi Arabia. Conclusions: Our results showed that the trend of HCV seroprevalence over time among MIDDLE EASTern blood donors was decreasing. It suggests that recent safety measures implemented in MIDDLE EASTern countries have been effective.

Cites

  • No record.

    • References

    Cite

    APA: Copy

    GHADERI ZEFREHI, HOSSEIN, SHARAFI, HEIDAR, SADEGHI, FARZIN, GHOLAMI FESHARAKI, MOHAMMAD, FARASAT, ALIREZA, JAHANPEYMA, FATEMEH, & ALAVIAN, SEYED MOAYED. (2017). SEROPREVALENCE OF HEPATITIS C VIRUS AMONG BLOOD DONORS IN MIDDLEEASTERN COUNTRIES: A SYSTEMATIC REVIEW AND META-ANALYSIS. IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ), 19(12), 0-0. SID. https://sid.ir/paper/293832/en

    Vancouver: Copy

    GHADERI ZEFREHI HOSSEIN, SHARAFI HEIDAR, SADEGHI FARZIN, GHOLAMI FESHARAKI MOHAMMAD, FARASAT ALIREZA, JAHANPEYMA FATEMEH, ALAVIAN SEYED MOAYED. SEROPREVALENCE OF HEPATITIS C VIRUS AMONG BLOOD DONORS IN MIDDLEEASTERN COUNTRIES: A SYSTEMATIC REVIEW AND META-ANALYSIS. IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ)[Internet]. 2017;19(12):0-0. Available from: https://sid.ir/paper/293832/en

    IEEE: Copy

    HOSSEIN GHADERI ZEFREHI, HEIDAR SHARAFI, FARZIN SADEGHI, MOHAMMAD GHOLAMI FESHARAKI, ALIREZA FARASAT, FATEMEH JAHANPEYMA, and SEYED MOAYED ALAVIAN, “SEROPREVALENCE OF HEPATITIS C VIRUS AMONG BLOOD DONORS IN MIDDLEEASTERN COUNTRIES: A SYSTEMATIC REVIEW AND META-ANALYSIS,” IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ), vol. 19, no. 12, pp. 0–0, 2017, [Online]. Available: https://sid.ir/paper/293832/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top